BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

497 related articles for article (PubMed ID: 23862076)

  • 21. [Mechanism of action of antidepressants and therapeutic perspectives].
    Bourin M; David DJ; Jolliet P; Gardier A
    Therapie; 2002; 57(4):385-96. PubMed ID: 12422559
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Rapid-onset antidepressant efficacy of glutamatergic system modulators: the neural plasticity hypothesis of depression.
    Wang J; Jing L; Toledo-Salas JC; Xu L
    Neurosci Bull; 2015 Feb; 31(1):75-86. PubMed ID: 25488282
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Long-term adaptive changes induced by serotonergic antidepressant drugs.
    Faure C; Mnie-Filali O; Haddjeri N
    Expert Rev Neurother; 2006 Feb; 6(2):235-45. PubMed ID: 16466303
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Possible contribution of IGF-1 to depressive disorder.
    Szczęsny E; Slusarczyk J; Głombik K; Budziszewska B; Kubera M; Lasoń W; Basta-Kaim A
    Pharmacol Rep; 2013; 65(6):1622-31. PubMed ID: 24553010
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The long-lasting antidepressant effects of rapastinel (GLYX-13) are associated with a metaplasticity process in the medial prefrontal cortex and hippocampus.
    Burgdorf J; Zhang XL; Weiss C; Gross A; Boikess SR; Kroes RA; Khan MA; Burch RM; Rex CS; Disterhoft JF; Stanton PK; Moskal JR
    Neuroscience; 2015 Nov; 308():202-11. PubMed ID: 26343295
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Neurotrophic factors and neuroplasticity pathways in the pathophysiology and treatment of depression.
    Levy MJF; Boulle F; Steinbusch HW; van den Hove DLA; Kenis G; Lanfumey L
    Psychopharmacology (Berl); 2018 Aug; 235(8):2195-2220. PubMed ID: 29961124
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Neural plasticity to stress and antidepressant treatment.
    Duman RS; Malberg J; Thome J
    Biol Psychiatry; 1999 Nov; 46(9):1181-91. PubMed ID: 10560024
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Neural plasticity mechanism of depression].
    Xu L
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2008 Apr; 33(4):326-30. PubMed ID: 18460777
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Neural Plasticity Associated with Hippocampal PKA-CREB and NMDA Signaling Is Involved in the Antidepressant Effect of Repeated Low Dose of Yueju Pill on Chronic Mouse Model of Learned Helplessness.
    Zou Z; Chen Y; Shen Q; Guo X; Zhang Y; Chen G
    Neural Plast; 2017; 2017():9160515. PubMed ID: 29075536
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antiapoptotic and neurotrophic effects of antidepressants: a review of clinical and experimental studies.
    Drzyzga ŁR; Marcinowska A; Obuchowicz E
    Brain Res Bull; 2009 Jun; 79(5):248-57. PubMed ID: 19480984
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Neuroplasticity and depression].
    Czéh B; Simon M
    Psychiatr Hung; 2005; 20(1):4-17. PubMed ID: 16389729
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of curcumin on chronic, unpredictable, mild, stress-induced depressive-like behaviour and structural plasticity in the lateral amygdala of rats.
    Zhang L; Luo J; Zhang M; Yao W; Ma X; Yu SY
    Int J Neuropsychopharmacol; 2014 May; 17(5):793-806. PubMed ID: 24405689
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [New perspectives of the mechanism of action of antidepressants arised from genomic theory of depression].
    Cereseto M; Ferrero A
    Vertex; 2003; 14(51):30-5. PubMed ID: 12690407
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Increasing doses of ketamine curtail antidepressant responses and suppress associated synaptic signaling pathways.
    Kim JW; Monteggia LM
    Behav Brain Res; 2020 Feb; 380():112378. PubMed ID: 31760154
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [ECT: from neuronal plasticity to mechanisms underlying antidepressant medication effect].
    Holtzmann J; Polosan M; Baro P; Bougerol T
    Encephale; 2007 Sep; 33(4 Pt 1):572-8. PubMed ID: 18033145
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Neuronal plasticity: a link between stress and mood disorders.
    Calabrese F; Molteni R; Racagni G; Riva MA
    Psychoneuroendocrinology; 2009 Dec; 34 Suppl 1():S208-16. PubMed ID: 19541429
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Agmatine, by Improving Neuroplasticity Markers and Inducing Nrf2, Prevents Corticosterone-Induced Depressive-Like Behavior in Mice.
    Freitas AE; Egea J; Buendia I; Gómez-Rangel V; Parada E; Navarro E; Casas AI; Wojnicz A; Ortiz JA; Cuadrado A; Ruiz-Nuño A; Rodrigues ALS; Lopez MG
    Mol Neurobiol; 2016 Jul; 53(5):3030-3045. PubMed ID: 25966970
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A molecular and cellular theory of depression.
    Duman RS; Heninger GR; Nestler EJ
    Arch Gen Psychiatry; 1997 Jul; 54(7):597-606. PubMed ID: 9236543
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Tetramethylpyrazine Produces Antidepressant-Like Effects in Mice Through Promotion of BDNF Signaling Pathway.
    Jiang B; Huang C; Chen XF; Tong LJ; Zhang W
    Int J Neuropsychopharmacol; 2015 Jan; 18(8):. PubMed ID: 25618406
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The neural plasticity theory of depression: assessing the roles of adult neurogenesis and PSA-NCAM within the hippocampus.
    Wainwright SR; Galea LA
    Neural Plast; 2013; 2013():805497. PubMed ID: 23691371
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 25.